Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001104659-25-094527
Filing Date
2025-09-29
Accepted
2025-09-29 16:33:17
Documents
74
Period of Report
2025-06-30

Document Format Files

Seq Description Document Type Size
1 10-K nnvc-20250630x10k.htm   iXBRL 10-K 2239727
2 EX-23 nnvc-20250630xex23.htm EX-23 4506
3 EX-31.1 nnvc-20250630xex31d1.htm EX-31.1 13577
4 EX-31.2 nnvc-20250630xex31d2.htm EX-31.2 13064
5 EX-32.1 nnvc-20250630xex32d1.htm EX-32.1 6841
6 EX-32.2 nnvc-20250630xex32d2.htm EX-32.2 6908
  Complete submission text file 0001104659-25-094527.txt   7339598

Data Files

Seq Description Document Type Size
7 EX-101.SCH nnvc-20250630.xsd EX-101.SCH 50072
8 EX-101.CAL nnvc-20250630_cal.xml EX-101.CAL 41618
9 EX-101.DEF nnvc-20250630_def.xml EX-101.DEF 228972
10 EX-101.LAB nnvc-20250630_lab.xml EX-101.LAB 398347
11 EX-101.PRE nnvc-20250630_pre.xml EX-101.PRE 320686
77 EXTRACTED XBRL INSTANCE DOCUMENT nnvc-20250630x10k_htm.xml XML 919287
Mailing Address 1 CONTROLS DRIVE SHELTON CT 06484
Business Address 1 CONTROLS DRIVE SHELTON CT 06484 (203) 668-5580
NANOVIRICIDES, INC. (Filer) CIK: 0001379006 (see all company filings)

EIN.: 760674577 | State of Incorp.: NV | Fiscal Year End: 0630
Type: 10-K | Act: 34 | File No.: 001-36081 | Film No.: 251356620
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)